BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17059148)

  • 1. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
    Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
    Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.
    Schmid A; Thybusch A; Kremer B; Henne-Bruns D
    Hepatogastroenterology; 2000; 47(32):579-85. PubMed ID: 10791243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended lymph-node dissection for gastric cancer.
    Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
    N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rational evaluation of different lymph node dissection].
    Chen JQ; Wang SB; Qi CL
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrectomy with radical D2 lymph node excision--effective and economically standardized therapy of adenocarcinoma of the stomach].
    Schmid A; Thybusch A; Henne-Bruns D; Kremer B
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1066-8. PubMed ID: 9574334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
    Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
    Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D3 versus D2 dissection in stomach carcinoma. A case-control study of postoperative morbidity, survival and early oncologic outcome].
    Bittorf BR; Günther F; Merkel S; Horbach T; Hohenberger W; Günther K
    Chirurg; 2002 Apr; 73(4):336-47. PubMed ID: 12063918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the gastric cardia: treatment via a left thoracoabdominal approach.
    Lekakos LN; Triantafillopoulos JK; Milingos ND; Sfikakis PG
    Am Surg; 2002 Jul; 68(7):584-90. PubMed ID: 12132737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience with lymphadenectomy in gastric cancer surgery].
    Montori J; Peparini N
    G Chir; 1998; 19(11-12):433-43. PubMed ID: 9882945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
    Reis E; Kama NA; Doganay M; Atli M; Dolapci M
    Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer.
    Hanazaki K; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
    Hepatogastroenterology; 1999; 46(28):2677-82. PubMed ID: 10522064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended (D2) lymphadenectomy in gastric cancer: a five year experience.
    Pugliese R; Maggioni D; Berardi V; Scandroglio I; Pisani D; Mariani A; Di Lernia S; Valli C; Cocotta E
    Int Surg; 2000; 85(3):209-15. PubMed ID: 11324997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of extensive lymph node dissection on the survival of early gastric cancer.
    Ohgaki M; Toshio T; Akeo H; Yamasaki J; Togawa T
    Hepatogastroenterology; 1999; 46(27):2096-9. PubMed ID: 10430404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
    Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
    Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of D2 lymphadenectomy in the surgical treatment of gastric carcinoma].
    Buris L; Halász L; Sasi SL; Czakó D
    Magy Seb; 2002 Aug; 55(4):257-60. PubMed ID: 12236082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.